Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Mutations Conferring Increased Sensitivity to Tripartite Motif 22 Restriction Accumulated Progressively in the Nucleoprotein of Seasonal Influenza A (H1N1) Viruses between 1918 and 2009.

Pagani I, Di Pietro A, Oteiza A, Ghitti M, Mechti N, Naffakh N, Vicenzi E.

mSphere. 2018 Apr 4;3(2). pii: e00110-18. doi: 10.1128/mSphere.00110-18. Print 2018 Apr 25.

2.

FoxO4 negatively controls Tat-mediated HIV-1 transcription through the post-transcriptional suppression of Tat encoding mRNA.

Oteiza A, Mechti N.

J Gen Virol. 2017 Jul;98(7):1864-1878. doi: 10.1099/jgv.0.000837. Epub 2017 Jul 12.

PMID:
28699853
3.

Interferon-inducible ribonuclease ISG20 inhibits hepatitis B virus replication through directly binding to the epsilon stem-loop structure of viral RNA.

Liu Y, Nie H, Mao R, Mitra B, Cai D, Yan R, Guo JT, Block TM, Mechti N, Guo H.

PLoS Pathog. 2017 Apr 11;13(4):e1006296. doi: 10.1371/journal.ppat.1006296. eCollection 2017 Apr.

4.

Control of FoxO4 Activity and Cell Survival by TRIM22 Directs TLR3-Stimulated Cells Toward IFN Type I Gene Induction or Apoptosis.

Oteiza A, Mechti N.

J Interferon Cytokine Res. 2015 Nov;35(11):859-74. doi: 10.1089/jir.2015.0020. Epub 2015 Aug 3.

PMID:
26237181
5.

TRIM22 inhibits influenza A virus infection by targeting the viral nucleoprotein for degradation.

Di Pietro A, Kajaste-Rudnitski A, Oteiza A, Nicora L, Towers GJ, Mechti N, Vicenzi E.

J Virol. 2013 Apr;87(8):4523-33. doi: 10.1128/JVI.02548-12. Epub 2013 Feb 13.

6.

Polyinosinic-polycytidylic acid induces the expression of interferon-stimulated gene 20 in mesangial cells.

Imaizumi T, Tanaka H, Mechti N, Matsumiya T, Yoshida H, Sato F, Aizawa-Yashiro T, Tsuruga K, Hayakari R, Satoh K.

Nephron Exp Nephrol. 2011;119(2):e40-8. doi: 10.1159/000328923. Epub 2011 Aug 10.

PMID:
21832855
7.

The human T-cell leukemia virus type 1 oncoprotein tax controls forkhead box O4 activity through degradation by the proteasome.

Oteiza A, Mechti N.

J Virol. 2011 Jul;85(13):6480-91. doi: 10.1128/JVI.00036-11. Epub 2011 Apr 27.

8.

TRIM22 inhibits HIV-1 transcription independently of its E3 ubiquitin ligase activity, Tat, and NF-kappaB-responsive long terminal repeat elements.

Kajaste-Rudnitski A, Marelli SS, Pultrone C, Pertel T, Uchil PD, Mechti N, Mothes W, Poli G, Luban J, Vicenzi E.

J Virol. 2011 May;85(10):5183-96. doi: 10.1128/JVI.02302-10. Epub 2011 Feb 23.

9.

The viral RNA recognition sensor RIG-I is degraded during encephalomyocarditis virus (EMCV) infection.

Papon L, Oteiza A, Imaizumi T, Kato H, Brocchi E, Lawson TG, Akira S, Mechti N.

Virology. 2009 Oct 25;393(2):311-8. doi: 10.1016/j.virol.2009.08.009. Epub 2009 Sep 4.

10.

TRIM22 E3 ubiquitin ligase activity is required to mediate antiviral activity against encephalomyocarditis virus.

Eldin P, Papon L, Oteiza A, Brocchi E, Lawson TG, Mechti N.

J Gen Virol. 2009 Mar;90(Pt 3):536-45. doi: 10.1099/vir.0.006288-0.

PMID:
19218198
11.

Identification of interferon-beta-stimulated genes that inhibit angiogenesis in vitro.

Taylor KL, Leaman DW, Grane R, Mechti N, Borden EC, Lindner DJ.

J Interferon Cytokine Res. 2008 Dec;28(12):733-40. doi: 10.1089/jir.2008.0030.

PMID:
18937547
12.

Expression of interferon-stimulated gene 20 in vascular endothelial cells.

Imaizumi T, Mechti N, Matsumiya T, Sakaki H, Kubota K, Yoshida H, Kimura H, Satoh K.

Microbiol Immunol. 2008 Jan;52(1):30-5. doi: 10.1111/j.1348-0421.2008.00004.x.

13.

Regulation of the interferon-inducible p53 target gene TRIM22 (Staf50) in human T lymphocyte activation.

Obad S, Olofsson T, Mechti N, Gullberg U, Drott K.

J Interferon Cytokine Res. 2007 Oct;27(10):857-64.

PMID:
17970695
14.

Altered memory capacities and response to stress in p300/CBP-associated factor (PCAF) histone acetylase knockout mice.

Maurice T, Duclot F, Meunier J, Naert G, Givalois L, Meffre J, Célérier A, Jacquet C, Copois V, Mechti N, Ozato K, Gongora C.

Neuropsychopharmacology. 2008 Jun;33(7):1584-602. Epub 2007 Sep 5.

15.

ISG20, an actor of the innate immune response.

Degols G, Eldin P, Mechti N.

Biochimie. 2007 Jun-Jul;89(6-7):831-5. Epub 2007 Mar 15.

PMID:
17445960
16.

A20/TNFAIP3, a new estrogen-regulated gene that confers tamoxifen resistance in breast cancer cells.

Vendrell JA, Ghayad S, Ben-Larbi S, Dumontet C, Mechti N, Cohen PA.

Oncogene. 2007 Jul 12;26(32):4656-67. Epub 2007 Feb 12.

PMID:
17297453
17.

Expression of the IFN-inducible p53-target gene TRIM22 is down-regulated during erythroid differentiation of human bone marrow.

Obad S, Olofsson T, Mechti N, Gullberg U, Drott K.

Leuk Res. 2007 Jul;31(7):995-1001. Epub 2007 Jan 24.

PMID:
17257675
18.

The exonuclease ISG20 mainly localizes in the nucleolus and the Cajal (Coiled) bodies and is associated with nuclear SMN protein-containing complexes.

Espert L, Eldin P, Gongora C, Bayard B, Harper F, Chelbi-Alix MK, Bertrand E, Degols G, Mechti N.

J Cell Biochem. 2006 Aug 1;98(5):1320-33.

PMID:
16514659
19.

Interferon-induced exonuclease ISG20 exhibits an antiviral activity against human immunodeficiency virus type 1.

Espert L, Degols G, Lin YL, Vincent T, Benkirane M, Mechti N.

J Gen Virol. 2005 Aug;86(Pt 8):2221-9.

PMID:
16033969
20.

Extracellular matrix in bone marrow can mediate drug resistance in myeloma.

Vincent T, Mechti N.

Leuk Lymphoma. 2005 Jun;46(6):803-11. Review.

PMID:
16019524
21.

The exonuclease ISG20 is directly induced by synthetic dsRNA via NF-kappaB and IRF1 activation.

Espert L, Rey C, Gonzalez L, Degols G, Chelbi-Alix MK, Mechti N, Gongora C.

Oncogene. 2004 Jun 3;23(26):4636-40.

PMID:
15064705
22.

IL-6 regulates CD44 cell surface expression on human myeloma cells.

Vincent T, Mechti N.

Leukemia. 2004 May;18(5):967-75.

PMID:
15014527
24.

[Interferon : antiviral mechanisms and viral escape].

Espert L, Gongora C, Mechti N.

Bull Cancer. 2003 Feb;90(2):131-41. Review. French.

25.

ISG20, a new interferon-induced RNase specific for single-stranded RNA, defines an alternative antiviral pathway against RNA genomic viruses.

Espert L, Degols G, Gongora C, Blondel D, Williams BR, Silverman RH, Mechti N.

J Biol Chem. 2003 May 2;278(18):16151-8. Epub 2003 Feb 19.

26.

Drug specific resistance to oxaliplatin is associated with apoptosis defect in a cellular model of colon carcinoma.

Gourdier I, Del Rio M, Crabbé L, Candeil L, Copois V, Ychou M, Auffray C, Martineau P, Mechti N, Pommier Y, Pau B.

FEBS Lett. 2002 Oct 9;529(2-3):232-6.

27.

Identifying intercellular signaling genes expressed in malignant plasma cells by using complementary DNA arrays.

De Vos J, Couderc G, Tarte K, Jourdan M, Requirand G, Delteil MC, Rossi JF, Mechti N, Klein B.

Blood. 2001 Aug 1;98(3):771-80.

28.

The human interferon- and estrogen-regulated ISG20/HEM45 gene product degrades single-stranded RNA and DNA in vitro.

Nguyen LH, Espert L, Mechti N, Wilson DM 3rd.

Biochemistry. 2001 Jun 19;40(24):7174-9.

PMID:
11401564
29.
31.

The interferon-inducible Staf50 gene is downregulated during T cell costimulation by CD2 and CD28.

Gongora C, Tissot C, Cerdan C, Mechti N.

J Interferon Cytokine Res. 2000 Nov;20(11):955-61.

PMID:
11096452
32.

A unique ISRE, in the TATA-less human Isg20 promoter, confers IRF-1-mediated responsiveness to both interferon type I and type II.

Gongora C, Degols G, Espert L, Hua TD, Mechti N.

Nucleic Acids Res. 2000 Jun 15;28(12):2333-41.

33.

[Interferon signaling pathways].

Gongora C, Mechti N.

Bull Cancer. 1999 Nov;86(11):911-9. French.

34.

Molecular cloning of a new interferon-induced PML nuclear body-associated protein.

Gongora C, David G, Pintard L, Tissot C, Hua TD, Dejean A, Mechti N.

J Biol Chem. 1997 Aug 1;272(31):19457-63.

35.

Cloning and expression of an alternatively spliced mRNA encoding a soluble form of the human interleukin-6 signal transducer gp130.

Diamant M, Rieneck K, Mechti N, Zhang XG, Svenson M, Bendtzen K, Klein B.

FEBS Lett. 1997 Jul 28;412(2):379-84.

36.

Assignment of ISG20 encoding a new interferon-induced PML nuclear body-associated protein, to chromosome 15q26 by in situ hybridization.

Mattei MG, Tissot C, Gongora C, Mechti N.

Cytogenet Cell Genet. 1997;79(3-4):286-7. No abstract available.

PMID:
9605874
37.

Both human alpha/beta and gamma interferons upregulate the expression of CD48 cell surface molecules.

Tissot C, Rebouissou C, Klein B, Mechti N.

J Interferon Cytokine Res. 1997 Jan;17(1):17-26.

PMID:
9041467
38.

Localization of Staf50, a member of the Ring finger family, to 11p15 by fluorescence in situ hybridization.

Tissot C, Taviaux SA, Diriong S, Mechti N.

Genomics. 1996 May 15;34(1):151-3. No abstract available.

PMID:
8661041
40.

Cell delivery and mechanisms of action of antisense oligonucleotides.

Leonetti JP, Degols G, Clarenc JP, Mechti N, Lebleu B.

Prog Nucleic Acid Res Mol Biol. 1993;44:143-66. Review. No abstract available.

PMID:
8434122
41.

In vivo footprints between the murine c-myc P1 and P2 promoters.

Plet A, Tourkine N, Mechti N, Jeanteur P, Blanchard JM.

Oncogene. 1992 Sep;7(9):1847-51.

PMID:
1501892
42.

Antisense inhibitors of HIV: problems and perspectives.

Degols G, Leonetti JP, Milhaud P, Mechti N, Lebleu B.

Antiviral Res. 1992 Apr;17(4):279-87. Review. No abstract available.

PMID:
1642480
43.

Sequence requirements for premature transcription arrest within the first intron of the mouse c-fos gene.

Mechti N, Piechaczyk M, Blanchard JM, Jeanteur P, Lebleu B.

Mol Cell Biol. 1991 May;11(5):2832-41.

44.

Intracellular distribution of microinjected antisense oligonucleotides.

Leonetti JP, Mechti N, Degols G, Gagnor C, Lebleu B.

Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2702-6.

45.

Antiproliferative effects of antisense oligonucleotides directed to the RNA of c-myc oncogene.

Degols G, Leonetti JP, Mechti N, Lebleu B.

Nucleic Acids Res. 1991 Feb 25;19(4):945-8.

46.

Nuclear location of synthetic oligonucleotides microinjected somatic cells: its implication in an antisense strategy.

Mechti N, Leonetti JP, Clarenc JP, Degols G, Lebleu B.

Nucleic Acids Symp Ser. 1991;(24):147-50.

PMID:
1668686
47.

c-myc and c-fos gene regulation during mouse liver regeneration.

Sobczak J, Mechti N, Tournier MF, Blanchard JM, Duguet M.

Oncogene. 1989 Dec;4(12):1503-8.

PMID:
2512526
48.

In situ and in vitro evidence for intragenic binding of nuclear factors at the murine c-myc locus.

Tourkine N, Mechti N, Piechaczyk M, Jeanteur P, Blanchard JM.

Oncogene. 1989 Aug;4(8):973-8.

PMID:
2548146
49.

Role of RNA structures in c-myc and c-fos gene regulations.

Piechaczyk M, Blanchard JM, Bonnieu A, Fort P, Mechti N, Rech J, Cuny M, Marty L, Ferré F, Lebleu B, et al.

Gene. 1988 Dec 10;72(1-2):287-95.

PMID:
2468569
50.

The regulatory strategies of c-myc and c-fos proto-oncogenes share some common mechanisms.

Blanchard JM, Piechaczyk M, Fort P, Bonnieu A, Mechti N, Rech J, Cuny M, Lebleu B, Jeanteur P.

Biochimie. 1988 Jul;70(7):877-84. Review.

PMID:
3145022

Supplemental Content

Loading ...
Support Center